The early and accurate classification of brain tumors is crucial for guiding effective treatment strategies and improving patient outcomes. This study presents BrainFusion, a significant advancement in brain tumor analysis using magnetic resonance imaging (MRI) by combining fine-tuned convolutional neural networks (CNNs) for tumor classification--including VGG16, ResNet50, and Xception--with YOLOv8 for precise tumor localization with bounding boxes. Leveraging the Brain Tumor MRI Dataset, our experiments reveal that the fine-tuned VGG16 model achieves test accuracy of 99.86%, substantially exceeding previous benchmarks. Beyond setting a new accuracy standard, the integration of bounding-box localization and explainable AI techniques further enhances both the clinical interpretability and trustworthiness of the system's outputs. Overall, this approach underscores the transformative potential of deep learning in delivering faster, more reliable diagnoses, ultimately contributing to improved patient care and survival rates.

The detection of brain tumor in MRI is an important aspect of ensuring timely diagnostics and treatment; however, manual analysis is commonly long and error-prone. Current approaches are not universal because they have limited generalization to heterogeneous tumors, are computationally inefficient, are not interpretable, and lack transparency, thus limiting trustworthiness. To overcome these issues, we introduce MobileDenseAttn, a fusion model of dual streams of MobileNetV2 and DenseNet201 that can help gradually improve the feature representation scale, computing efficiency, and visual explanations via GradCAM. Our model uses feature level fusion and is trained on an augmented dataset of 6,020 MRI scans representing glioma, meningioma, pituitary tumors, and normal samples. Measured under strict 5-fold cross-validation protocols, MobileDenseAttn provides a training accuracy of 99.75%, a testing accuracy of 98.35%, and a stable F1 score of 0.9835 (95% CI: 0.9743 to 0.9920). The extensive validation shows the stability of the model, and the comparative analysis proves that it is a great advancement over the baseline models (VGG19, DenseNet201, MobileNetV2) with a +3.67% accuracy increase and a 39.3% decrease in training time compared to VGG19. The GradCAM heatmaps clearly show tumor-affected areas, offering clinically significant localization and improving interpretability. These findings position MobileDenseAttn as an efficient, high performance, interpretable model with a high probability of becoming a clinically practical tool in identifying brain tumors in the real world.

Brain tumors show significant health challenges due to their potential to cause critical neurological functions. Early and accurate diagnosis is crucial for effective treatment. In this research, we propose ResLink, a novel deep learning architecture for brain tumor classification using CT scan images. ResLink integrates novel area attention mechanisms with residual connections to enhance feature learning and spatial understanding for spatially rich image classification tasks. The model employs a multi-stage convolutional pipeline, incorporating dropout, regularization, and downsampling, followed by a final attention-based refinement for classification. Trained on a balanced dataset, ResLink achieves a high accuracy of 95% and demonstrates strong generalizability. This research demonstrates the potential of ResLink in improving brain tumor classification, offering a robust and efficient technique for medical imaging applications.

Brain plays a crucial role in regulating body functions and cognitive processes, with brain tumors posing significant risks to human health. Precise and prompt detection is a key factor in proper treatment and better patient outcomes. Traditional methods for detecting brain tumors, that include biopsies, MRI, and CT scans often face challenges due to their high costs and the need for specialized medical expertise. Recent developments in machine learning (ML) and deep learning (DL) has exhibited strong capabilities in automating the identification and categorization of brain tumors from medical images, especially MRI scans. However, these classical ML models have limitations, such as high computational demands, the need for large datasets, and long training times, which hinder their accessibility and efficiency. Our research uses MobileNET model for efficient detection of these tumors. The novelty of this project lies in building an accurate tumor detection model which use less computing re-sources and runs in less time followed by efficient decision making through the use of image processing technique for accurate results. The suggested method attained an average accuracy of 98.5%.

Generative Adversarial Networks (GAN) have shown potential in expanding limited medical imaging datasets. This study explores how different ratios of GAN-generated and real brain tumor MRI images impact the performance of a CNN in classifying healthy vs. tumorous scans. A DCGAN was used to create synthetic images which were mixed with real ones at various ratios to train a custom CNN. The CNN was then evaluated on a separate real-world test set. Our results indicate that the model maintains high sensitivity and precision in tumor classification, even when trained predominantly on synthetic data. When only a small portion of GAN data was added, such as 900 real images and 100 GAN images, the model achieved excellent performance, with test accuracy reaching 95.2%, and precision, recall, and F1-score all exceeding 95%. However, as the proportion of GAN images increased further, performance gradually declined. This study suggests that while GANs are useful for augmenting limited datasets especially when real data is scarce, too much synthetic data can introduce artifacts that affect the model's ability to generalize to real world cases.

Detecting Glioma, Meningioma, and Pituitary Tumors, and Normal Brain Tissues based on Y olov11 and Y olov8 Deep Learning Models Ahmed M. Taha a, Salah A. Aly b,c, Mohamed F. Darwish d a Dept. of CE, Faculty of Engineering, Egypt University of Informatics, Cairo, Egypt b Faculty of Computing and Data Science, Badya University, Giza, Egypt c CS&Math Branch, Faculty of Science, Fayoum University, Fayoum, Egypt d Dept. of Pathology, Faculty of Medicine, Badya University, Giza, Egypt Abstract --Accurate and quick diagnosis of normal brain tissue Glioma, Meningioma, and Pituitary T umors is crucial for optimal treatment planning and improved medical results. Magnetic Resonance Imaging (MRI) is widely used as a non-invasive diagnostic tool for detecting brain abnormalities, including tumors. However, manual interpretation of MRI scans is often time-consuming, prone to human error, and dependent on highly specialized expertise. This paper proposes an advanced AI-driven technique to detecting glioma, meningioma, and pituitary brain tumors using Y oloV11 and Y oloV8 deep learning models. Methods: Using a transfer learning-based fine-tuning approach, we integrate cutting-edge deep learning techniques with medical imaging to classify brain tumors into four categories: No-T umor, Glioma, Meningioma, and Pituitary T umors.

One of the primary challenges in medical diagnostics is the accurate and efficient use of magnetic resonance imaging (MRI) for the detection of brain tumors. But the current machine learning (ML) approaches have two major limitations, data privacy and high latency. To solve the problem, in this work we propose a federated learning architecture for a better accurate brain tumor detection incorporating the YOLOv11 algorithm. In contrast to earlier methods of centralized learning, our federated learning approach protects the underlying medical data while supporting cooperative deep learning model training across multiple institutions. To allow the YOLOv11 model to locate and identify tumor areas, we adjust it to handle MRI data. To ensure robustness and generalizability, the model is trained and tested on a wide range of MRI data collected from several anonymous medical facilities. The results indicate that our method significantly maintains higher accuracy than conventional approaches.

Identifying the extent of brain tumors is a significant challenge in brain cancer treatment. The main difficulty is in the approximate detection of tumor size. Magnetic resonance imaging (MRI) has become a critical diagnostic tool. However, manually detecting the boundaries of brain tumors from MRI scans is a labor-intensive task that requires extensive expertise. Deep learning and computer-aided detection techniques have led to notable advances in machine learning for this purpose. In this paper, we propose a modified You Only Look Once (YOLOv8) model to accurately detect the tumors within the MRI images. The proposed model replaced the Non-Maximum Suppression (NMS) algorithm with a Real-Time Detection Transformer (RT- DETR) in the detection head. NMS filters out redundant or overlapping bounding boxes in the detected tumors, but they are hand-designed and pre-set. RT-DETR removes hand-designed components. The second improvement was made by replacing the normal convolution block with ghost convolution. Ghost Convolution reduces computational and memory costs while maintaining high accuracy and enabling faster inference, making it ideal for resource-constrained environments and real-time applications. The third improvement was made by introducing a vision transformer block in the backbone of YOLOv8 to extract context-aware features. We used a publicly available dataset of brain tumors in the proposed model. The proposed model performed better than the original YOLOv8 model and also performed better than other object detectors (Faster R- CNN, Mask R-CNN, YOLO, YOLOv3, YOLOv4, YOLOv5, SSD, RetinaNet, EfficientDet, and DETR). The proposed model achieved 0.91 mAP (mean Average Precision)@0.5.

Model checking is an automatic technique for verifying the correctness properties of safety-critical reactive systems. This method has been successfully applied to find subtle errors in complex systems. Model checking techniques have a wide range of application domains, among which large-scale distributed systems [1-3], signal [4], and medical images analysis [5-8]. The research related to the last topic is still ongoing looking for the perfect (precise, complete, simple) approach for analyzing medical images. The use of model checking is relatively recent, in particular regarding the verification of the analysis of medical images. In this domain, model checking in medical images has shown to be a promising application that can significantly facilitate the work of professionals. What motivates us in this study, considering that model checking is increasingly used in testing to check whether a system model satisfies a property, is to take model checking in its usual role to take on more advanced roles in medical image analysis by applying model-checking logic to medical images and detection of tumors in addition to validation of properties through tests or case studies.

Advance in medical imaging is an important part in deep learning research. One of the goals of computer vision is development of a holistic, comprehensive model which can identify tumors from histology slides obtained via biopsies. A major problem that stands in the way is lack of data for a few cancer-types. In this paper, we ascertain that data augmentation using GANs can be a viable solution to reduce the unevenness in the distribution of different cancer types in our dataset. Our demonstration showed that a dataset augmented to a 50% increase causes an increase in tumor detection from 80% to 87.5%